ACHCAcadia Healthcare Company, Inc.

Ticker: ACHC | Price: $37.42 | Today's Change: +16.06%

---

What Happened

Acadia Healthcare Company, Inc. filed an 8-K with the SEC on November 4, 2026, disclosing its financial results for the third quarter of fiscal year 2026 under Items 2.02, 7.01, and 9.01. Revenue came in at $2.491 billion for Q3 FY2026, while net income was a comparatively thin $8.374 million, translating to both basic and diluted earnings per share of $0.82. The sharp divergence between top-line scale and bottom-line profitability makes this filing particularly notable for investors tracking the company's margin trajectory.

---

Why It Matters

The headline numbers paint a mixed picture:

• Revenue of $2.491 billion demonstrates that Acadia continues to operate at significant scale within the behavioral health sector.
• Net income of just $8.374 million on nearly $2.5 billion in revenue implies a net margin of approximately 0.34% — an extremely thin result that will draw scrutiny around operating costs, interest expense, and any one-time charges that may have weighed on the quarter.
• EPS of $0.82 (both basic and diluted) is the figure investors will anchor to most directly when comparing against consensus estimates, though those estimates are not available within the structured filing data provided.
• The stock's +16.06% move today suggests the market interpreted these results — or accompanying guidance or commentary in the press release — as meaningfully better than feared, possibly indicating that the bar heading into this quarter had been set very low.

It is worth noting that the structured XBRL data provided includes an operating income figure of $136.003 million tagged to Q1 FY2020, which does not correspond to the current quarter and is not used as a current-period datapoint in this report.

---

Analysis

The juxtaposition of a large revenue base and a razor-thin net income figure raises immediate questions about what is driving the cost structure. Behavioral health operators like Acadia typically face pressure from staffing costs, facility expenses, and debt service — any of which could account for the gap between $2.49 billion in revenue and only $8.4 million reaching the bottom line. Investors will want to scrutinize the full earnings release and any supplemental materials filed under Item 9.01 for segment-level detail, one-time items, and management's commentary on the path to margin improvement.

The magnitude of today's stock rally — over 16% — is striking given that StockWatch's initiating coverage, published September 9, 2026, reflected a cautious stance on the name. That the stock is now trading well above the level implied by prior research expectations suggests either a significant positive surprise in the underlying results or a sharp shift in sentiment around near-term risks that had been weighing on the share price. The key question going forward is whether the thin net margin is a structural feature of the current business or a transitional phenomenon that management believes is addressable. Watch for specific commentary on labor costs, facility ramp-up timelines, and any revisions to full-year guidance in the accompanying materials.

---

Disclaimer

This report is a news and informational summary of a publicly filed SEC disclosure. It does not constitute investment advice, a solicitation to buy or sell any security, or an equity research recommendation of any kind. No rating or price target is expressed or implied. Investors should conduct their own due diligence and consult a qualified financial adviser before making any investment decisions.

Existing Coverage

StockWatch has full coverage on ACHC, published 2026-09-09. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-11-04. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/1520697/000143774926034941/achc20261104_8k.htm